Literature DB >> 21310851

MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation.

Zhimin Ou1, Taira Wada, Roberto Gramignoli, Song Li, Stephen C Strom, Min Huang, Wen Xie.   

Abstract

The nuclear receptor liver X receptor (LXR) is a ligand-dependent transcription factor that plays an important role in the metabolism and homeostasis of cholesterol, lipids, bile acids, and steroid hormones. MicroRNAs (miRNAs) are recently recognized important negative regulators of gene expression. In this report, we showed that miRNA hsa-miR-613 played an important role in the autoregulation of the human LXRα gene. hsa-miR-613 targeted the endogenous LXRα through its specific miRNA response element (613MRE) within the LXRα 3'-untranslated region. Interestingly and paradoxically, the expression of hsa-miR-613 itself was induced upon the activation of LXR. However, hsa-miR-613 did not appear to be a direct LXR target gene. Instead, the positive regulation of hsa-miR-613 by LXR was mediated by the sterol regulatory element binding protein (SREBP)-1c, a known LXR target gene. Promoter analysis revealed an SREBP response element in the hsa-miR-613 gene promoter. Treatment with insulin also induced the expression of hsa-miR-613 in an SREBP-1c-dependent manner, further supporting the role of SREBP-1c in the positive regulation of this miRNA species. Finally, the autoinduction of LXRα by a LXR agonist was enhanced when hsa-miR-613 was inhibited or SREBP-1c was down-regulated. hsa-miR-613 appeared to specifically target the human LXRα. We propose that the negative regulation mediated by hsa-miR-613 and SREBP-1c and the previously reported positive regulation mediated by an LXR response element in the LXRα gene promoter constitute a ying-yang mechanism to ensure a tight regulation of this nuclear receptor of many metabolic functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310851      PMCID: PMC3063084          DOI: 10.1210/me.2010-0360

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

Review 1.  The liver X receptor gene team: potential new players in atherosclerosis.

Authors:  Joyce J Repa; David J Mangelsdorf
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 2.  Liver X receptor signaling pathways in cardiovascular disease.

Authors:  Peter Tontonoz; David J Mangelsdorf
Journal:  Mol Endocrinol       Date:  2003-04-10

3.  Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.

Authors:  Hirdesh Uppal; Simrat P S Saini; Antonio Moschetta; Ying Mu; Jie Zhou; Haibiao Gong; Yonggong Zhai; Songrong Ren; George K Michalopoulos; David J Mangelsdorf; Wen Xie
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

4.  How microRNAs choose their targets.

Authors:  Ivo L Hofacker
Journal:  Nat Genet       Date:  2007-10       Impact factor: 38.330

5.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

6.  Liver X receptors regulate adrenal cholesterol balance.

Authors:  Carolyn L Cummins; David H Volle; Yuan Zhang; Jeffrey G McDonald; Benoît Sion; Anne-Marie Lefrançois-Martinez; Françoise Caira; Georges Veyssière; David J Mangelsdorf; Jean-Marc A Lobaccaro
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 7.  MicroRNA biogenesis: isolation and characterization of the microprocessor complex.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Ramin Shiekhattar
Journal:  Methods Mol Biol       Date:  2006

8.  Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes.

Authors:  D Azzout-Marniche; D Bécard; C Guichard; M Foretz; P Ferré; F Foufelle
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

Review 9.  MicroRNAs in cancer: small molecules with a huge impact.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

10.  Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.

Authors:  Hirdesh Uppal; Yonggong Zhai; Archana Gangopadhyay; Shaheen Khadem; Songrong Ren; James A Moser; Wen Xie
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

View more
  38 in total

1.  Effects of radiotherapy on nasopharyngeal carcinoma cell invasiveness.

Authors:  Zheng Peng; Tiancai Xu; Xiaofang Liao; Huijuan He; Wansu Xu
Journal:  Tumour Biol       Date:  2015-08-29

Review 2.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

3.  MicroRNAs and Cardiovascular Disease.

Authors:  Carlos Fernández-Hernando; Angel Baldán
Journal:  Curr Genet Med Rep       Date:  2013-03

Review 4.  Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

Authors:  Kasey C Vickers; Praveen Sethupathy; Jeanette Baran-Gale; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

Review 5.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

Review 6.  Molecular mechanisms of fatty liver in obesity.

Authors:  Lixia Gan; Wei Xiang; Bin Xie; Liqing Yu
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 7.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

Review 8.  MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Neurobiol Dis       Date:  2014-06-05       Impact factor: 5.996

Review 9.  microRNAs and HDL life cycle.

Authors:  Alberto Canfrán-Duque; Cristina M Ramírez; Leigh Goedeke; Chin-Sheng Lin; Carlos Fernández-Hernando
Journal:  Cardiovasc Res       Date:  2014-06-03       Impact factor: 10.787

Review 10.  MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.

Authors:  Hyejin Yoon; Luis F Flores; Jungsu Kim
Journal:  Biochim Biophys Acta       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.